(Press-News.org) Blue Zones and the American College of Lifestyle Medicine (ACLM) today launched the “Blue Zones Certification Course for Physicians and Health Professionals.” The new certification recognizes clinicians with the knowledge and tools to promote longevity, well-being, and health equity—both in the exam room and in their communities.
The certification integrates Blue Zones' evidence-based roadmap to living better and longer, rooted in their identification of and research from the world's longest-lived and happiest cultures—the blue zones regions—with ACLM's expertise in therapeutic lifestyle interventions. Lifestyle medicine is a medical specialty that utilizes optimal nutrition, regular physical activity, restorative sleep, stress management, connectedness, and the avoidance of risky substances to treat, reverse, and prevent chronic diseases, such as cardiovascular diseases, type 2 diabetes, and obesity.
The online course is organized into modules that begin by introducing participants to the blue zones regions and the Power 9® principles—the lifestyle habits identified by Blue Zones founder Dan Buettner and his research team as being shared by the world’s longest-lived people. Subsequent modules explore Blue Zones’ environment-first approach to health and longevity, applying Blue Zones principles in communities, organizations, and into patient care. The final two modules challenge participants to personally practice Blue Zones lifestyle habits, serve as changemakers, and help drive community transformation.
The creation of the “Blue Zones-Certified Physician” and “Blue Zones-Certified Health Professional” designations is a significant milestone in the global impact partnership formed last year by ACLM and Blue Zones to address the unsustainable burden of chronic disease.
Ben Leedle, CEO of Blue Zones and Co-founder of Blue Zones Project®, said: “Blue Zones has proven that you can improve population health outside clinic walls by redesigning the places and systems in which people spend the most time. Lifestyle medicine has proven that evidence-based lifestyle interventions—like nutrition, movement, sleep, and stress management—can prevent, treat, and even reverse chronic diseases. This certification bridges our environment-first approach with medicine. When you converge ‘care of the patient’ with ‘health of the public,’ you don't just treat or reverse disease, you can prevent it at scale.”
To become a "Blue Zones-Certified Physician" or "Blue Zones-Certified Health Professional," clinicians must first earn lifestyle medicine board certification. In the U.S., physicians are certified by the American Board of Lifestyle Medicine (ABLM) while ACLM certifies eligible health professionals. Outside the U.S., the International Board of Lifestyle Medicine (IBLM) is the certification body for physicians and eligible health professionals.
Clinicians who achieve Blue Zones certification not only deepen their knowledge and skills but also benefit from Blue Zones’ global brand recognition. Patients can feel confident knowing they are receiving care rooted in the Blue Zones principles, while clinicians gain visibility for their Blue Zones Certification through ACLM’s searchable database of certified lifestyle medicine clinicians. Clinicians can also apply Blue Zones principles in their own lives to support their well-being and resilience.
“Clinicians who achieve Blue Zones Certification will stand out in their communities as leaders in the movement to transform healthcare from a system of ‘sick care’ to one of true health restoration,” said ACLM President Padmaja Patel, MD, DipABLM, FACLM, CPE. “This certification affirms their commitment to evidence-based, lifestyle-first approaches, while also providing them with the visibility, credibility, and brand recognition that helps strengthen the trust of patients, colleagues, and health systems alike."
Since the lifestyle medicine certification exam was first offered in 2017, the number of certified physicians and health professionals has grown rapidly to more than 8,000 worldwide. On average, more than 900 additional clinicians are certified each year. Growth in recent years has accelerated even further to nearly three times faster between 2023 and 2025, underscoring the rapid adoption of lifestyle medicine across the healthcare landscape. A record 1,728 individuals registered for the 2025 exam. The 2026 exam will be offered Nov. 21 to Dec. 6.
“The growth of lifestyle medicine has been nothing short of extraordinary, and the introduction of Blue Zones Certification builds on that momentum,” said Blue Zones Certification Course Lead Faculty Michelle Tollefson, MD, DipABLM, FACLM, FACOG. “This new certification pathway gives clinicians practical tools to extend their impact well beyond the exam room—into families, workplaces, and communities—while reinforcing the critical role of lifestyle interventions in treating, reversing, and preventing chronic disease.”
The Blue Zones–ACLM Fellows Program is currently in development and will offer deeper and more specialized training in lifestyle medicine principles aligned with the Blue Zones philosophy and research.
About ACLM®
The American College of Lifestyle Medicine (ACLM) is the nation’s medical professional society advancing the field of lifestyle medicine as the foundation of a redesigned, value-based and equitable healthcare delivery system, essential to achieving the Quintuple Aim and whole-person health. ACLM represents, advocates for, trains, certifies, and equips its members to identify and eradicate the root cause of chronic disease by optimizing modifiable risk factors. ACLM is filling the gaping void of lifestyle medicine in medical education, providing more than 1.2 million hours of lifestyle medicine education to physicians and other health professionals since 2004, while also advancing research, clinical practice and reimbursement strategies.
About Blue Zones®
Blue Zones employs evidence-based ways to help people live better, longer. The company's work is rooted in explorations and research done by founder and National Geographic Fellow Dan Buettner in blue zones regions around the world, where people live extraordinarily long and/or happy lives. The original research and findings were released in Buettner's bestselling books The Blue Zones Solution, The Blue Zones of Happiness, The Blue Zones, Thrive, and Blue Zones Kitchen, Blue Zones Challenge—all published by National Geographic books. A hit docuseries, Live to 100: Secrets of the Blue Zones, was released on Netflix in 2023. Using original Blue Zones research, Blue Zones works with cities and counties to make healthy choices easier through permanent and semi-permanent changes to our human-made surroundings. Participating communities have experienced double-digit drops in obesity and tobacco use and have saved millions of dollars in healthcare costs.
END
Blue Zones and American College of Lifestyle Medicine launch new Blue Zones® Certification for Physicians and Health Professionals
Clinicians who earn the certification will stand out in their communities for having the skills and knowledge to apply evidence-based lifestyle interventions and Blue Zones’ roadmap to living better, longer lives
2025-11-10
ELSE PRESS RELEASES FROM THIS DATE:
SwRI-developed bioreactor replicates versatile induced Pluripotent Stem Cells
2025-11-10
SAN ANTONIO — November 10, 2025 — Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.
SwRI scientists used the bioreactor to replicate induced Pluripotent Stem Cells (iPSCs) derived from adult skin, blood, and other somatic cells. Their pluripotent state allows iPSCs to differentiate into any other cell type in the body, much like embryonic stem cells but without the same ethical ambiguity. Large quantities ...
Trial showing ivermectin safety in small children could spur progress against several neglected tropical diseases
2025-11-10
Trial Showing Ivermectin Safety in Small Children Could Spur Progress Against Several Neglected Tropical Diseases
TORONTO (November 10, 2025)—Millions of very young children currently excluded from treatment with the drug ivermectin could be safely included in ongoing campaigns against challenging and often neglected tropical diseases such as intestinal worms, scabies and river blindness, according to results from a clinical trial presented today at the Annual Meeting of the American Society ...
Human approach is hypothesized to be superior to technology for supportive cancer care according to new data in JNCCN
2025-11-10
PLYMOUTH MEETING, PA [November 10, 2025] — New research in the November 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network explores the perceptions regarding the effectiveness of team-based and technology-based approaches for supportive care for people with cancer. The ongoing supportive care study includes discussions on patient goals, values, and preferences, in addition to symptom management. According to the results from this mixed-methods study, 87.5% of team-based clinic participants perceived that method is more ...
Mount Sinai’s Jean-Frédéric Colombel, MD, to deliver the 31st Anatomy Lesson in Amsterdam, highlighting global efforts to prevent and cure Crohn’s disease
2025-11-10
New York, NY (November 10 2025) — In a high honor, Jean-Frédéric Colombel, MD, a leading inflammatory bowel disease (IBD) expert at the Icahn School of Medicine at Mount Sinai, will deliver the 31st Anatomy Lesson on Thursday, November 20, at the Concertgebouw in Amsterdam. His lecture, “Tackling the Growing Problem of Immune Diseases—Crohn’s Disease as an Example,” will explore Mount Sinai’s pioneering work in the early detection, prevention, and treatment of IBD.
The Anatomy Lesson, an annual public lecture organized by Amsterdam UMC, invites leading international physicians and researchers to reflect on medicine’s ...
Breast cancer case study could inform clinical trials
2025-11-10
When researchers look for potential cancer therapy targets, they typically go after protein-coding genes that participate in disease progression. Disrupt them and negate whatever role they play in cancer’s development or spread. Researchers at Cold Spring Harbor Laboratory (CSHL) have also been working on another kind of target. They’re studying a long non-coding RNA called MALAT1. So far, it’s been linked to more than 20 different types of tumors.
In a new and unique study published in Molecular Therapy: Oncology, CSHL researchers track MALAT1 levels ...
Cherie Zachary, MD, installed as ACAAI President
2025-11-10
ORLANDO (NOV. 9, 2025) – Allergist Cherie Zachary, MD, of Bloomington, MN was installed as president of the American College of Allergy, Asthma and Immunology (ACAAI) at the ACAAI Annual Scientific Meeting on November 10 in Orlando. Allergist David Stukus, MD, of Columbus, OH, was elected ACAAI president-elect.
Other newly-elected ACAAI officers are Maureen Petersen, MD, of Clayton, NC, as vice president and Melinda Rathkopf, MD, MBA, of Atlanta, GA, as treasurer. Regents elected for three-year terms include Christopher C. Chang, MD, PhD, MBA, Hollywood, Florida, Mitchell H. Grayson, MD, Columbus, OH, and Jay A. Lieberman, ...
Billions live in environments that violate human rights
2025-11-10
More than 99% of the world’s 7.7 billion people have one or more of their environmental rights threatened, according to new research.
In the most comprehensive analysis of inequality in environmental conditions to date, CU Boulder researchers revealed that nearly half of the global population lives in regions facing three or more environmental problems. Those include polluted air, unsafe water, extreme heat, food insecurity and biodiversity loss.
The analysis was published September 25 in Environmental Research Communications.
It provides strong ...
Thyroid gland new possible target for prostate cancer treatment
2025-11-10
A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new study by an international research group led by Umeå University, Sweden, and the Medical University of Vienna, Austria. By blocking a receptor for the hormone, the growth of tumour cells in the prostate was inhibited. In the long term, the discovery may open up a new way of attacking certain types of aggressive prostate cancer.
"The results indicate that the receptor in question is a driving force in the growth of cancer. Substances that block it could thus be a target for future drugs against prostate cancer," ...
New study reveals devastating impact of cane toads approaching the Pilbara
2025-11-10
New Curtin University research has found invasive cane toads are on track to reach Western Australia’s Pilbara region within the next 10 to 20 years, threatening to cause widespread losses among native species and significant cultural and economic harm.
The study, published in Scientific Reports, predicts that without containment efforts, the toxic amphibians will colonise up to 75 per cent of the Pilbara within three decades, putting 25 native species at risk of serious population declines. These include several species of native marsupial predators like northern quolls, ghost bat and kaluta, as well as frog-eating snakes, blue-tongue skinks and goannas.
Of ...
COP30: Global nature goals at risk as conservation projects quietly fail
2025-11-10
As world leaders begin COP30 climate negotiations in Brazil this week, an international team co-led by a University of Sydney researcher has warned of a hidden crisis undermining global biodiversity and carbon targets: the quiet abandonment of conservation projects.
The comment paper, ‘Conservation abandonment is a policy blind spot’, published in Nature Ecology & Evolution, was co-led by Dr Matthew Clark, a postdoctoral researcher in the Thriving Oceans Research Hub at the University of Sydney and an honorary research associate in the Centre for Environmental Policy at Imperial College ...
LAST 30 PRESS RELEASES:
Long-term poverty and rising unsecured debt in early adulthood each linked to higher risk of premature death
A novel climate biostress model and sentinel system seeks to track global climate impacts
Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time
Suicide prevention program decreases risks, saves lives among people recently released from jail
Evolution of firearm mortality as the leading cause of death in the US pediatric population
Firearm homicide in pregnant women and state-level firearm ownership
Child abuse and neglect rates in the U.S. are dropping, but disparities exist
Cooperative motor proteins found to kill cancer cells when dual-inhibited
American College of Medical Genetics and Genomics releases new clinical practice resource on managing RAD51C, RAD51D, and BRIP1 variants
Discovery reveals why Alzheimer’s patients forget family, friends
Eco-friendly nanoparticles improve cidofovir’s anticancer and antiviral effects
English learners earn more high school credits in schools with greater teacher autonomy, collaboration, and advocacy for students
Mysterious ‘impossible’ merger of two massive black holes explained
Blue Zones and American College of Lifestyle Medicine launch new Blue Zones® Certification for Physicians and Health Professionals
SwRI-developed bioreactor replicates versatile induced Pluripotent Stem Cells
Trial showing ivermectin safety in small children could spur progress against several neglected tropical diseases
Human approach is hypothesized to be superior to technology for supportive cancer care according to new data in JNCCN
Mount Sinai’s Jean-Frédéric Colombel, MD, to deliver the 31st Anatomy Lesson in Amsterdam, highlighting global efforts to prevent and cure Crohn’s disease
Breast cancer case study could inform clinical trials
Cherie Zachary, MD, installed as ACAAI President
Billions live in environments that violate human rights
Thyroid gland new possible target for prostate cancer treatment
New study reveals devastating impact of cane toads approaching the Pilbara
COP30: Global nature goals at risk as conservation projects quietly fail
New treatment for combating iron deficiency more effectively
A new AI-powered method to automate material analysis and design
Security flaws in portable genetic sequencers risk leaking private DNA data
‘Roadmap’ shows the environmental impact of AI data center boom
Scientists discover chameleon’s telephone-cord-like optic nerves once overlooked by Aristotle and Newton
One enzyme could be behind alcohol addiction and liver disease
[Press-News.org] Blue Zones and American College of Lifestyle Medicine launch new Blue Zones® Certification for Physicians and Health ProfessionalsClinicians who earn the certification will stand out in their communities for having the skills and knowledge to apply evidence-based lifestyle interventions and Blue Zones’ roadmap to living better, longer lives